S&P gives Baxter notes A-

S&P said it assigned Baxter International Inc.’s proposed senior unsecured notes an A- rating.

“We continue to believe Baxter is well-positioned to withstand the ongoing headwinds related to the pandemic given the medically necessary nature of many of its products, its relatively low exposure to elective procedures, its good capacity for an underperformance at the current rating and its strong liquidity position with limited upcoming debt maturities,” S&P said in a press release.

The company is expected to use the proceeds to partially fund the redemption of its outstanding senior unsecured notes due October 2025.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.